Literature DB >> 18462821

Dehydroepiandrosterone, epiandrosterone and synthetic derivatives inhibit Junin virus replication in vitro.

Eliana G Acosta1, Andrea C Bruttomesso, Juan A Bisceglia, Mónica B Wachsman, Lydia R Galagovsky, Viviana Castilla.   

Abstract

In the present paper the in vitro antiviral activity of dehydroepiandrosterone (DHEA), epiandrosterone (EA) and 16 synthetic derivatives against Junin virus (JUNV) replication in Vero cells was studied. DHEA and EA caused a selective inhibition of the replication of JUNV and other members of the Arenaviridae family such as Pichinde virus and Tacaribe virus. The compounds were not virucidal to cell-free JUNV. The impairment of viral replication was not due to an inhibitory effect of the steroids on virus adsorption or internalization. An inhibitory effect of the compounds on JUNV protein synthesis and both intracellular and extracellular virus production was demonstrated. A partial inhibitory action on cell surface expression of JUNV glycoprotein G1 was also detected on DHEA- and EA-treated cultures. Like DHEA and EA, three compounds obtained from EA by chemical synthesis showed selectivity indexes higher than ribavirin, the only antiviral compound that has shown partial efficacy against arenavirus infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462821     DOI: 10.1016/j.virusres.2008.03.014

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  6 in total

1.  Ribavirin can be mutagenic for arenaviruses.

Authors:  Héctor Moreno; Isabel Gallego; Noemí Sevilla; Juan Carlos de la Torre; Esteban Domingo; Verónica Martín
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

Review 2.  Progress in the experimental therapy of severe arenaviral infections.

Authors:  Brian B Gowen; Mike Bray
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

3.  A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus.

Authors:  Sean Ekins; Joel S Freundlich; Megan Coffee
Journal:  F1000Res       Date:  2014-11-14

4.  Screening of novel synthetic derivatives of dehydroepiandrosterone for antivirals against flaviviruses infections.

Authors:  Muhammad Imran; Luping Zhang; Bohan Zheng; Zikai Zhao; Dengyuan Zhou; Shengfeng Wan; Zheng Chen; Hongyu Duan; Qiuyan Li; Xueqin Liu; Shengbo Cao; Shaoyong Ke; Jing Ye
Journal:  Virol Sin       Date:  2022-01-18       Impact factor: 4.327

5.  A systematic screen of FDA-approved drugs for inhibitors of biological threat agents.

Authors:  Peter B Madrid; Sidharth Chopra; Ian D Manger; Lynne Gilfillan; Tiffany R Keepers; Amy C Shurtleff; Carol E Green; Lalitha V Iyer; Holli Hutcheson Dilks; Robert A Davey; Andrey A Kolokoltsov; Ricardo Carrion; Jean L Patterson; Sina Bavari; Rekha G Panchal; Travis K Warren; Jay B Wells; Walter H Moos; Raelyn L Burke; Mary J Tanga
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

6.  Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants.

Authors:  Anna Maisa; Ute Ströher; Hans-Dieter Klenk; Wolfgang Garten; Thomas Strecker
Journal:  PLoS Negl Trop Dis       Date:  2009-06-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.